Largest health care biotech companies by market cap

Amgen leads the 24 health care biotech companies ranked by market value, at SEK 2.44T, ahead of Gilead Sciences (SEK 2.13T) and Moderna (SEK 809B). Figures as of 19 Nov 2026, 08:16 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenSEK 2.44T
Median
SEK 108B
Combined market value
SEK 8.5T
Countries
5

Market values as of .

All countries
Health Care
Biotech
SEK
Clear filters
Largest health care biotech companies by market cap
#CompanyMarket cap ↓PriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareSEK 2.44TSEK 4,509.72 3.07% down 34% up United States
2Gilead SciencesGILD · Health CareSEK 2.13TSEK 1,716.76 0.75% down 33% up United States
3ModernaMRNA · Health CareSEK 809BSEK 1,999.30 4.84% down 755% up United States
4argenxARGX · Health CareSEK 601.4BSEK 9,562.68 0.66% down 4% up Belgium
5BiogenBIIB · Health CareSEK 377.6BSEK 2,554.21 0.25% up 49% up United States
6Revolution MedicinesRVMD · Health CareSEK 351.2BSEK 1,623.70 1.76% down 131% up United States
7BioNTechBNTX · Health CareSEK 209.7BSEK 845.88 1.89% down 16% down Germany
8ExelixisEXEL · Health CareSEK 169.3BSEK 693.80 0.31% down 63% up United States
9Neurocrine BiosciencesNBIX · Health CareSEK 167.5BSEK 1,654.58 1.84% down 20% up United States
10Bio-TechneTECH · Health CareSEK 116.1BSEK 739.11 0.17% up 26% up United States
11RepligenRGEN · Health CareSEK 112.1BSEK 1,754.25 6.47% up 5% up United States
12Halozyme TherapeuticsHALO · Health CareSEK 111BSEK 973.28 0.18% down 37% up United States
13Kymera TherapeuticsKYMR · Health CareSEK 105.1BSEK 1,230.63 0.32% down 87% up United States
14QiagenQGEN · Health CareSEK 104BSEK 503.51 0.38% down 12% up Netherlands
15Krystal BiotechKRYS · Health CareSEK 94.9BSEK 3,203.71 5.62% up 46% up United States
16VaxcytePCVX · Health CareSEK 94.1BSEK 594.54 1.48% down 22% up United States
17Twist BioscienceTWST · Health CareSEK 80.6BSEK 1,182.06 3.88% up 340% up United States
18CG OncologyCGON · Health CareSEK 72.6BSEK 812.76 1.34% up 85% up United States
19ImmunityBioIBRX · Health CareSEK 72.4BSEK 68.07 7.03% up 193% up United States
20ImmunovantIMVT · Health CareSEK 69.7BSEK 336.99 0.12% down 43% up United States
21Kodiak SciencesKOD · Health CareSEK 65BSEK 993.71 1.04% up 396% up United States
22Scholar Rock HoldingSRRK · Health CareSEK 59.5BSEK 487.66 6.48% up 14% up United States
23Adaptive BiotechnologiesADPT · Health CareSEK 46.8BSEK 289.14 0.11% down 88% up United States
24CRISPR TherapeuticsCRSP · Health CareSEK 39.6BSEK 408.31 0.10% up 21% down Switzerland

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1595 SEK).

Questions and answers

Which health care biotech companies rank first by market value?

Amgen (SEK 2.44T), Gilead Sciences (SEK 2.13T) and Moderna (SEK 809B) are the top three of the 24 health care biotech companies ranked by market value as of 19 Nov 2026, 08:16 UTC.

How many health care biotech companies are in this ranking?

24 are ranked by market value.

What are these health care biotech companies worth together?

The 24 health care biotech companies ranked by market value have a combined market value of SEK 8.5T as of 19 Nov 2026, 08:16 UTC.

What does ranking by market value measure?

What the stock market values the whole company at: its share price times the number of its shares.

Cite this page

Funkfolio, “Largest health care biotech companies by market cap”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?sector=health-care

Underlying data: Yahoo Finance; SEC EDGAR.